about
Targeting mitochondrial dysfunction in lung diseases: emphasis on mitophagyEfficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosisDisruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.Mitochondrial NADH dehydrogenase in cystic fibrosis: enzyme kinetics in cultured fibroblasts.Selection of nonmucoid derivatives of mucoid Pseudomonas aeruginosa is strongly influenced by the level of iron in the culture medium.Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant miceCFTR activity and mitochondrial function.Redox balance in cystic fibrosis.Characterization of mitochondrial function in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.Cystic fibrosis--a lethal exocrinopathy with altered mitochondrial calcium metabolism.Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms.Purinergic Antagonism Prevents Mitochondrial Dysfunction and Behavioral Deficits Associated with Dopaminergic Toxicity Induced by 6-OHDA in Rats.CrossTalk proposal: Skeletal muscle oxidative capacity is altered in patients with cystic fibrosis.Piracetam Attenuates LPS-Induced Neuroinflammation and Cognitive Impairment in Rats.Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.Differential Alterations of the Mitochondrial Morphology and Respiratory Chain Complexes during Postnatal Development of the Mouse Lung.Muscle function and resting energy expenditure in female athletes with cystic fibrosis.Kinetic alterations of cytochrome-c oxidase in cystic fibrosis
P2860
Q26992144-B6EDA941-1D16-4F45-8234-B436952AA6EBQ33605166-F9F14747-94BE-4217-98DD-E28207FCDDD7Q33717303-9A622782-07F0-48BF-9F58-6D7E92306FEDQ34489613-3D00E831-6A2B-4D52-A1EF-85701CA2A773Q35202993-E33001D9-08B7-46CF-8E2B-2686F2B21690Q36331557-E40EAFED-FA52-4128-8567-050463F40967Q37098621-71C22B3F-7F72-41DE-B60A-9AB7DF001855Q37133567-F8764B3B-E50D-4035-99AB-ED488EE96E9BQ38198442-3F056C97-7DFB-4809-A2F3-B76AC8425A81Q38871529-7004B8A2-886C-4545-B045-72F478159637Q39767174-4838FDB2-AC20-42FB-90A6-F2186D7AD4E4Q47738847-B900AA6E-B6D4-4274-97F6-B22FA7494A7DQ47760346-B77DE8E2-527E-4A0F-A071-B4B75966CCB3Q48181537-E42F8B49-10C1-4E00-9986-1BD6CCF97FDDQ48318995-78E25A3B-EABD-461B-ADD6-170C59029B04Q48335945-2BA8BEF6-2469-4EFA-B13D-9141DA6DB39EQ49837362-64591575-9A11-4453-84AA-3A397A643C18Q51653377-68DD9D0A-1243-455E-B4D3-B760720A4932Q57245690-8E3A441F-0732-41C1-A632-F362568F5A4B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@en
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@nl
type
label
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@en
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@nl
prefLabel
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@en
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@nl
P2093
P2860
P356
P1476
Mitrochondrial NADH dehydrogenase in cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.76.6.2979
P407
P577
1979-06-01T00:00:00Z